Loading clinical trials...
Loading clinical trials...
Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)
Conditions
Interventions
Autologous (self) mononuclear cells derived from umbilical cord blood
Stage II Surgical repair
Locations
8
United States
Children's of Alabama
Birmingham, Alabama, United States
Children's Hospital of Los Angeles
Los Angeles, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Ocshner Medical Center
New Orleans, Louisiana, United States
Children's Hospitals of Minnesota
Minneapolis, Minnesota, United States
Cincinnati Children's Hospital and Medical Center
Cincinnati, Ohio, United States
Start Date
June 6, 2019
Primary Completion Date
May 22, 2022
Completion Date
February 1, 2026
Last Updated
July 8, 2025
NCT06711666
NCT05386173
NCT06461676
NCT02919956
NCT03079401
NCT04056416
Lead Sponsor
Timothy J Nelson, MD, PhD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions